Cited by 1,345BRCA gene mutations in cancerCancer Genomics and DiagnosticsGenomics and Rare Diseases

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Germline Mutations in Predisposition Genes in Pediatric Cancer

Open access

Zhang, Jinghui, Walsh, Michael F., Wu, Gang, Edmonson, Michael N., Gruber, Tanja A., Easton, John, Hedges, Dale, Ma, Xiaotu, Zhou, Xin, Yergeau, Donald A., Wilkinson, Mark R., Vadodaria, Bhavin, Chen, Xiang, McGee, Rose B., Hines-Dowell, Stacy, Nuccio, Regina, Quinn, Emily, Shurtleff, Sheila A., Rusch, Michael, Patel, Aman, Becksfort, Jared B., Wang, Shuoguo, Weaver, Meaghann S., Ding, Li, Mardis, Elaine R., Wilson, Richard K., Gajjar, Amar, Ellison, David W., Pappo, Alberto S., Pui, Ching-Hon, Nichols, Kim E., Downing, James R.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1508054PMC PMC4734119

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS: In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancer-predisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS: Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS: Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients. (Funded by the American Lebanese Syrian Associated Charities and the National Cancer Institute.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1508054

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Enhancements and modifications of primer design program Primer3
Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citation

Flagged first, then by citations

Show all 56 references

2 of the 56 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Lindor NM, 2008, J Natl Cancer Inst Monogr, 1
Meldrum C, 2011, Clin Biochem Rev, 32, 177
Armes JE, 1999, Cancer Res, 59, 2011

Sorted by citations

Items 401–500 of 1,000

Nervous system (NS) Tumors in Cancer Predisposition Syndromes
Patil, P., Pencheva, B., Patil, V. M., & Fangusaro, J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01277-w · Cited by 22
Causes of Childhood Cancer: A Review of the Recent Literature: Part I—Childhood Factors
Ricci, A. M., Emeny, R. T., Bagley, P. J., Blunt, H. B., Butow, M. E., Morgan, A., Alford‐Teaster, J., Titus, L. J., Walston, R. R., & Rees, J. R. (2024) · Cancers · doi:10.3390/cancers16071297 · Cited by 24
Prevalence of hereditary cancer susceptibility syndromes in children with cancer in a highly consanguineous population
Jastaniah, W. A., Al‐Jefri, A., Ayas, M. F., Alharbi, M., Alkhayat, N., Al‐Anzi, F., Yassin, F., Al-Kasim, F., Alharbi, Q. K., Abdullah, S., et al. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.05.006 · Cited by 20
Parent–child communication surrounding genetic testing for Li–Fraumeni syndrome: Living under the cloud of cancer
Valdez, J. M., Walker, B. S., Ogg, S. W., Gattuso, J. S., Alderfer, M. A., Zelley, K., Ford, C. A., Baker, J. N., Mandrell, B. N., & Nichols, K. E. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27350 · Cited by 20
Self-citation
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
Rutkowski, S., Modena, P., Williamson, D., Kerl, K., Nysom, K., Pizer, B. L., Bartels, U. K., Puget, S., Doz, F., Michalski, A. J., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30364-4 · Cited by 20
Pediatric leukemia: Moving toward more accurate models
Milan, T., Canaj, H., Villeneuve, C., Ghosh, A., Barabé, F., Cellot, S., & Wilhelm, B. T. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.05.003 · Cited by 22
Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor
Henderson, T. O., Fowler, B., Hamann, H. A., Nathan, P. C., Whitton, J. A., Leisenring, W. M., Oeffinger, K. C., Neglia, J. P., Turcotte, L. M., Arnold, M., et al. (2021) · Cancer · doi:10.1002/cncr.33922 · Cited by 20
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma
Scatolini, M., Grisanti, S., Tomaiuolo, P., Grosso, E., Basile, V., Cosentini, D., Puglisi, S., Laganà, M., Perotti, P., Saba, L., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114088 · Cited by 21
Insights from Large-Scale Cancer Genome Sequencing
Mardis, E. R. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-122035 · Cited by 20
Self-citation
The landscape of coding RNA editing events in pediatric cancer
Wen, J., Rusch, M., Brady, S. W., Shao, Y., Edmonson, M. N., Shaw, T. I., Powers, B. B., Tian, L., Easton, J. B., Mullighan, C. G., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08956-5 · Cited by 19
Self-citation
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group
Toss, A., Quarello, P., Mascarin, M., Banna, G. L., Zecca, M., Cinieri, S., Peccatori, F. A., & Ferrari, A. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01213-3 · Cited by 19
Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours
van der Graaf, W. T. A., Tesselaar, M. E. T., McVeigh, T. P., Oyen, W. J. G., & Fröhling, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.011 · Cited by 20
Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
McGee, R. B., Oak, N., Harrison, L. H., Xu, K., Nuccio, R., Blake, A. K., Mostafavi, R. M., Lewis, S., Taylor, L. M., Kubal, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2482 · Cited by 20
Self-citation
Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial
McGill, B. C., Wakefield, C. E., Tucker, K., Daly, R. A., Donoghoe, M. W., Vetsch, J., Warby, M., Fuentes-Bolanos, N., Barlow-Stewart, K. K., Kirk, J., et al. (2023) · Cancer · doi:10.1002/cncr.34917 · Cited by 19
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy
Ahmadi, S. E., Rahimian, E., Rahimi, S., Zarandi, B., Bahraini, M., Soleymani, M., Safdari, S. M., Shabannezhad, A., Jaafari, N., & Safa, M. (2024) · Biomarker Research · doi:10.1186/s40364-024-00676-9 · Cited by 22
A diagnostic approach to bone tumours
Flanagan, A. M., & Lindsay, D. (2017) · Pathology · doi:10.1016/j.pathol.2017.08.003 · Cited by 19
The dawn of “immune-revolution” in children: early experiences with checkpoint inhibitors in childhood malignancies
Lucchesi, M., Sardi, I., Puppo, G., Chella, A., & Favre, C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3450-2 · Cited by 19
Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition
Gambale, A., Russo, R., Andolfo, I., Quaglietta, L., Rosa, G. D., Contestabile, V., Martino, L. D., Genesio, R., Pignataro, P., Giglio, S., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13600 · Cited by 19
Current Approaches to Germline Cancer Genetic Testing
Stoffel, E. M., & Carethers, J. M. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-052318-101009 · Cited by 22
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
Byron, S. A., Hendricks, W. P. D., Nagulapally, A. B., Kraveka, J. M., Ferguson, W. S., Brown, V. I., Eslin, D. E., Mitchell, D., Cornelius, A., Roberts, W. D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1033 · Cited by 20
Integrating genetic counseling and testing in the pediatric oncology setting: Parental attitudes and influencing factors
Desrosiers, L., Quinn, E. A., Cramer, S., & Dobek, W. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27907 · Cited by 19
Self-citation
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families
van Marcke, C., Helaers, R., Leener, A. D., Merhi, A., Schoonjans, C. A., Ambroise, J., Galant, C., Delrée, P., Rothé, F., Bar, I., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01273-y · Cited by 18
Germline BRCA2 mutations detected in pediatric sequencing studies impact parents’ evaluation and carePreprint
Walsh, M. F., Kennedy, J. A., Harlan, M., Kentsis, A., Shukla, N. N., Musinsky, J., Roberts, S. S., Kung, A. L., Robson, M. E., Kushner, B. H., et al. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001925 · Cited by 19
Self-citation
Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups
Robbins, C. T., Bou-Dargham, M. J., Sanchez, K. G., Rosen, M. C., & Sang, Q. A. (2018) · Journal of Cancer · doi:10.7150/jca.27993 · Cited by 18
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
Lin, P., Yeh, Y., Wu, P., Hsu, K., Chang, J., & Shen, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-40571-0 · Cited by 18
Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
Ghonime, M. G., Saini, U., Kelly, M. C., Roth, J. C., Wang, P.-Y., Chen, C., Miller, K. E., Hernandez-Aguirre, I., Kim, Y., Mo, X. M., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002939 · Cited by 18
Self-citation
Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care
Gargallo, P., Oltra, S., Yáñez, Y., Ribelles, A. J., Calabria, I., Segura, V., Lázaro, M., Balaguer, J., Alcañiz, M. T. T., Dolz, S., et al. (2021) · Cancers · doi:10.3390/cancers13215339 · Cited by 18
Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia
Douglas, S. P. M., Lahtinen, A., Koski, J., Leimi, L., Keränen, M. A. I., Koskenvuo, M., Heckman, C. A., Jahnukainen, K., Pitkänen, E., Wartiovaara‐Kautto, U., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14364-x · Cited by 18
Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care
Shahani, S. A., & Marcotte, E. L. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1011873 · Cited by 19
Genetic predisposition to cancers in children and adolescents
Nakano, Y., Rabinowicz, R., & Malkin, D. M. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001197 · Cited by 18
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Stout, L. A., Hunter, C., Schroeder, C., Kassem, N., & Schneider, B. P. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00374-9 · Cited by 18
The Cost of Cure: Chronic Conditions in Survivors of Child, Adolescent, and Young Adult Cancers
Signorelli, C., Fardell, J. E., Wakefield, C. E., Webber, K., & Cohn, R. J. (2016) · Springer eBooks · doi:10.1007/978-981-10-1844-2_13 · Cited by 18
Synonymous mutation in TP53 results in a cryptic splice site affecting its DNA‐binding site in an adolescent with two primary sarcomas
Austin, F., Oyarbide, U., Massey, G. V., Grimes, M. M., & Corey, S. J. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26584 · Cited by 18
Concomitant IDH wild‐type glioblastoma and IDH1‐mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome
Galuppini, F., Opocher, E., Tabori, U. Y., Mammi, I., Edwards, M., Campbell, B. B., Kelly, J., Viel, A., Quaia, M., Rivieri, F., et al. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12450 · Cited by 18
Effective identification of cancer predisposition syndromes in children with cancer employing a questionnaire
Schwermer, M., Behnert, A., Dörgeloh, B. B., Ripperger, T., & Kratz, C. P. (2021) · Familial Cancer · doi:10.1007/s10689-021-00233-5 · Cited by 18
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology
Shah, S. M., Demidova, E. V., Lesh, R. W., Hall, M. J., Daly, M. B., Meyer, J. E., Edelman, M. J., & Arora, S. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102337 · Cited by 17
Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy
Rossini, L., Durante, C., Bresolin, S., Opocher, E., Marzollo, A., & Biffi, A. (2022) · Cancers · doi:10.3390/cancers14153741 · Cited by 18
Recognizing and Managing Children with a Pediatric Cancer Predisposition Syndrome: A Guide for the Pediatrician
Coury, S. A., Schneider, K. A., Schienda, J., & Tan, W. (2018) · Pediatric Annals · doi:10.3928/19382359-20180424-02 · Cited by 18
Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours
Chan, S. H., Chew, W. H. W., Ishak, N. D. B., Lim, W. K., Li, S.-T., Tan, S. H., Teo, J. X., Shaw, T., Chang, K. T. E., Chen, Y., et al. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0070-7 · Cited by 18
Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions
Brodeur, G. M., Diller, L., Nichols, K. E., Plon, S. E., Porter, C. C., & Malkin, D. M. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0423 · Cited by 17
Self-citation
Somatic mutation panels: Time to clear their names
Trottier, A. M., Silva, M. C. D. A., Li, Z., & Godley, L. A. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.04.065 · Cited by 18
Ethical Challenges in Pediatric Oncology Care and Clinical Trials
Benedetti, D. J., & Marron, J. M. (2021) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-63749-1_11 · Cited by 18
BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma
Maurer, L. M., Daley, J. D., Mukherjee, E., Venier, R. E., Julian, C. M., Bailey, N. G., Jacobs, M. F., Kumar‐Sinha, C., Raphael, H., Periyapatna, N., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0047 · Cited by 17
Germline MUTYH mutations and high‐grade gliomas: Novel evidence for a potential association
Bedics, G., Kotmayer, L., Zajta, E., Hegyi, L. L., Brückner, E. Á., Rajnai, H., Reiniger, L., Bödör, C., Garami, M., & Scheich, B. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23054 · Cited by 17
Maternal diabetes and childhood cancer risks in offspring: two population-based studies
Huang, X., Hansen, J., Lee, P., Wu, C., Federman, N. C., Arah, O. A., Li, C., Olsen, J., Ritz, B. R., & Heck, J. E. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01961-w · Cited by 17
The contribution of mosaicism to genetic diseases and de novo pathogenic variants
Tinker, R. J., Bastarache, L. A., Ezell, K. M., Kobren, S. N., Esteves, C., Rosenfeld, J. A., Macnamara, E. F., Hamid, R., Cogan, J. D., Rinker, D. C., et al. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63309 · Cited by 17
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
Bertrums, E. J. M., de Kanter, J. K., Derks, L. L. M., Verheul, M., Trabut, L., van Roosmalen, M. J., Hasle, H., Antoniou, E., Reinhardt, D., Dworzak, M. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50384-z · Cited by 16
Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia
de Smith, A. J., Ojha, J., Francis, S. S., Sanders, E., Endicott, A. A., Hansen, H. M., Smirnov, I. V., Termuhlen, A. M., Walsh, K. M., Metayer, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12238 · Cited by 17
Precision medicine approaches for the management of Ewing sarcoma: current perspectives
Rizk, V. T., Walko, C. M., & Brohl, A. S. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s170612 · Cited by 17
Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations
Dumbrava, E. I., Brusco, L., Daniels, M. S., Wathoo, C., Shaw, K. R. M., Lu, K. H., Zheng, X., Strong, L. C., Litton, J. K., Arun, B., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00143 · Cited by 17
Entering the era of precision medicine in pediatric oncology
Hadjadj, D., Deshmukh, S., & Jabado, N. (2020) · Nature Medicine · doi:10.1038/s41591-020-1119-6 · Cited by 17
Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort
Foss-Skiftesvik, J., Stoltze, U. K., Hansen, T. V. O., Ahlborn, L. B., Sørensen, E., Ostrowski, S. R., Kullegaard, S. M. A., Laspiur, A. O., Melchior, L. C., Scheie, D., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01429-1 · Cited by 17
Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre study
Postema, F. A. M., Hopman, S. M. J., de Borgie, C. A. J. M., Hammond, P., Hennekam, R. C. M., Merks, J. H. M., on behalf of the TuPS study group, Aalfs, C. M., Anninga, J., Berger, L. P. V., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013237 · Cited by 17
The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies
Trubicka, J., Żemojtel, T., Hecht, J., Falana, K., Piekutowska‐Abramczuk, D., Płoski, R., Perek‐Polnik, M., Drogosiewicz, M., Grajkowska, W., Ciara, E., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3211-y · Cited by 17
Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children’s Oncology Group
Diessner, B. J., Pankratz, N., Hooten, A. J., Mirabello, L., Sarver, A. L., Mills, L. J., Malkin, D., Kelley, A. C., & Spector, L. G. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00087 · Cited by 16
Predisposition Footprints in the Somatic Genome of Wilms Tumors
Treger, T. D., Wegert, J., Wenger, A., Coorens, T. H. H., Al‐Saadi, R., Kemps, P. G., Kennedy, J., Parks, C., Anderson, N. D., Hodder, A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0878 · Cited by 16
Molecular Biology of Childhood Leukemia
Alexander, T., & Mullighan, C. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-043020-110055 · Cited by 18
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms
Baranwal, A., Hahn, C. N., Shah, M. V., & Hiwase, D. (2022) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-022-00676-2 · Cited by 16
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
Subasri, V., Light, N. D., Kanwar, N., Brzezinski, J. J., Luo, P., Hansford, J. R., Cairney, E., Portwine, C., Elser, C., Finlay, J. L., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0402 · Cited by 16
Self-citation
Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development
Pires, S. F., de Barros, J. S., da Costa, S. S., do Carmo, G. B., Scliar, M. O., Lengert, A. V. H., Boldrini, É., da Silva, S. R. M., Vidal, D. O., Maschietto, M. C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310463 · Cited by 16
The evolutionary impact of childhood cancer on the human gene pool
Stoltze, U. K., Foss-Skiftesvik, J., Hansen, T. V. O., Rasmussen, S., Karczewski, K. J., Wadt, K., & Schmiegelow, K. (2024) · Nature Communications · doi:10.1038/s41467-024-45975-9 · Cited by 17
Performance of Tumor Surveillance for Children With Cancer Predisposition
Blake, A., Perrino, M. R., Morin, C. E., Taylor, L. M., McGee, R. B., Lewis, S., Hines‐Dowell, S. J., Pandey, A. S., Turner, P., Kubal, M., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.1878 · Cited by 16
Self-citation
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
Aldoss, I. T., Douer, D., & Pullarkat, V. A. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.06.001 · Cited by 16
Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers
Wang, Z., Rice, S. V., Chang, T., Liu, Y., Liu, Q., Qin, N., Putnam, D. K., Shelton, K., Lanctot, J. Q., Wilson, C. L., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz210 · Cited by 16
Self-citation
Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing
Srivastava, A., Giangiobbe, S., Kumar, A., Paramasivam, N., Dymerska, D., Behnisch, W., Witzens‐Harig, M., Lubiński, J., Hemminki, K., Försti, A., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00179 · Cited by 16
Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis
Muskens, I. S., Feng, Q., Francis, S. S., Walsh, K. M., McKean‐Cowdin, R., Gauderman, W. J., de Smith, A. J., & Wiemels, J. L. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa089 · Cited by 16
Expanding cancer predisposition genes with ultra-rare cancer-exclusive human variations
Rasnic, R., Linial, N., & Linial, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70494-0 · Cited by 17
Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer Therapy
Schneider, B. P., Stout, L. A., Philips, S., Schroeder, C., Scott, S. F., Hunter, C., Kassem, N., Kiel, P. J., & Radovich, M. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00354 · Cited by 16
Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors
Cullinan, N. M., Schiller, I., Giuseppe, G. D., Mamun, M. R. I., Reichman, L., Cacciotti, C., Wheaton, L., Caswell, K., DiMonte, B., Gibson, P. J., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00018 · Cited by 16
Childhood acute myeloid leukemia shows a high level of germline predisposition
Samaraweera, S. E., Wang, P. P.-S., Li, K. L., Casolari, D. A., Feng, J., Pinese, M., Maung, K. Z. Y., Leo, P., Cowley, M. J., Perkins, K., et al. (2021) · Blood · doi:10.1182/blood.2021012666 · Cited by 16
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution
Richter‐Pechańska, P., Kunz, J. B., Rausch, T., Erarslan-Uysal, B., Bornhauser, B. C., Frismantas, V., Assenov, Y., Zimmermann, M., Happich, M., Doeberitz, C. V. K., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01587-0 · Cited by 20
Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas
Madubata, C. J., Alireza Roshan-ghias, A., Chu, T. H., Resnick, S. J., Zhao, J., Arnes, L., Wang, J., & Rabadán, R. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0032-5 · Cited by 17
Cerebellar tumors
Stücklin, A. G., & Grotzer, M. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64189-2.00019-6 · Cited by 16
Germline Rare Deleterious Variant Load Alters Cancer Risk, Age of Onset and Tumor Characteristics
Selvan, M. E., Onel, K., Gnjatic, S., Klein, R. J., & Gumus, Z. H. (2022) · npj Precision Oncology · doi:10.1038/s41698-023-00354-3 · Cited by 15
Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing
Alba‐Pavón, P., Alaña, L., Gutiérrez-Jimeno, M., García‐Obregón, S., Imízcoz, T., Panizo, E., Urdiales, P. G., Echebarria-Barona, A., Almaraz, R. L., Zaldumbide, L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29982-2 · Cited by 15
Genomics-Driven Precision Medicine in Pediatric Solid Tumors
Suthapot, P., Chiangjong, W., Chaiyawat, P., Choochuen, P., Pruksakorn, D., Sangkhathat, S., Hongeng, S., Anurathapan, U., & Chutipongtanate, S. (2023) · Cancers · doi:10.3390/cancers15051418 · Cited by 17
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers
Lim, W. C., Costa, M. E. M. D., Godefroy, K., Jacquet, E., Gragert, L. A., Rondof, W., Marchais, A., Nhiri, N., Dalfovo, D., Viard, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1265469 · Cited by 17
SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
Kolekar, P. S., Balagopal, V., Dong, L., Liu, Y., Foy, S. G., Tran, Q., Mulder, H. L., Huskey, A. L. W., Plyler, E. M., Liang, Z., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1063 · Cited by 17
Self-citation
Pediatric Cancer Genetics
Dean, S. J., & Farmer, M. (2017) · Elsevier eBooks · doi:10.1016/c2016-0-01345-1 · Cited by 15
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
Hattinger, C. M., Patrizio, M. P., Tavanti, E., Luppi, S., Magagnoli, F., Picci, P., & Serra, M. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1535903 · Cited by 15
Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria
Reschke, M., Biewald, E. M., Bronstein, L., Brecht, I. B., Dittner‐Moormann, S., Driever, F., Ebinger, M., Fleischhack, G., Grabow, D., Geismar, D., et al. (2021) · Cancers · doi:10.3390/cancers13081876 · Cited by 15
Lynch syndrome: further defining the pediatric spectrum
Self, C., Suttman, A., Schneider, K. W., & Hoffman, L. M. (2021) · Cancer Genetics · doi:10.1016/j.cancergen.2021.07.002 · Cited by 15
Primary lung carcinoma in children and adolescents – Clinical characteristics and outcome of 12 cases from the German registry for rare paediatric tumours (STEP)
Voggel, S., Abele, M., Seitz, C. M., Agaimy, A., Vokuhl, C., Dirksen, U., Bier, A., Flaadt, T., Classen, C. F., Claviez, A., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.08.004 · Cited by 15
Unraveling the Genetic Architecture of Hepatoblastoma Risk: Birth Defects and Increased Burden of Germline Damaging Variants in Gastrointestinal/Renal Cancer Predisposition and DNA Repair Genes
Aguiar, T. F. M., Teixeira, A. C. B., Scliar, M. O., de Barros, J. S., Lemes, R. B., Souza, S., Tolezano, G. C., dos Santos, F. A., Tojal, I., Cypriano, M., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.858396 · Cited by 16
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care
Summers, R. J., Castellino, S. M., Porter, C. C., MacDonald, T. J., Basu, G. D., Szelinger, S., Bhasin, M., Cash, T., Carter, A. B., Castellino, R. C., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00451 · Cited by 15
Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes
Schmiegelow, K. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.02.006 · Cited by 15
Cell death-based treatment of childhood cancer
Westhoff, M., Marschall, N., Grunert, M., Karpel‐Massler, G., Burdach, S. E. G., & Debatin, K. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0062-z · Cited by 15
A Survey of Compound Heterozygous Variants in Pediatric Cancers and Structural Birth Defects
Miller, D. B., & Piccolo, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.640242 · Cited by 15
Risk factors for subsequent endocrine-related cancer in childhood cancer survivors
Wijnen, M., van den Heuvel‐Eibrink, M. M., Medici, M., Peeters, R. P., van der Lely, A. J., & Neggers, S. J. C. M. M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0113 · Cited by 15
Sarcoma and germ-line DICER1 mutations
de Kock, L., & Foulkes, W. D. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30522-8 · Cited by 15
Osteosarcoma through the Lens of Bone Development, Signaling, and MicroenvironmentPreprint
Young, E. P., Marinoff, A. E., López-Fuentes, E., & Sweet-Cordero, A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041635 · Cited by 14
Detecting likely germline variants during tumor-based molecular profiling
Jaber, D. A., Zhang, J., & Godley, L. A. (2025) · Journal of Clinical Investigation · doi:10.1172/jci190264 · Cited by 13
Self-citation
The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients
Wagener, R., Walter, C., Auer, F., Alzoubi, D., Hauer, J., Fischer, U., Varghese, J., Dugas, M., Borkhardt, A., & Brozou, T. (2022) · International Journal of Cancer · doi:10.1002/ijc.34390 · Cited by 14
The performance of multi-gene panels for breast/ovarian cancer predisposition
Nunziato, M., Scaglione, G. L., Maggio, F. D., Nardelli, C., Capoluongo, E., & Salvatore, F. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.007 · Cited by 15
Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort
Stoltze, U. K., Hildonen, M., Hansen, T. V. O., Foss-Skiftesvik, J., Byrjalsen, A., Lundsgaard, M., Pignata, L., Grønskov, K., Tümer, Z., Schmiegelow, K., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108982 · Cited by 14
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
Weiser, A., Bergman, A. S., Machaalani, C., Bennett, J., Roth, P., Reimann, R., Nazarian, J., & Stücklin, A. G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1254645 · Cited by 17
Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer
van der Tuin, K., Ruano, D., Knijnenburg, J., van der Luijt, R. B., Morreau, H., Links, T. P., Hes, F. J., Hesselink, M. S. K., Nies, M., Bocca, G., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae107 · Cited by 14
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma
Friker, L. L., Perwein, T., Waha, A., Dörner, E., Klein, R., Blattner-Johnson, M., Layer, J. P., Sturm, D., Nussbaumer, G., Kwiecien, R., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02846-x · Cited by 17
Homologous recombination in budding yeast expressing the human RAD52 gene reveals a Rad51-independent mechanism of conservative double-strand break repair
Manthey, G. M., Clear, A. D., Liddell, L. C., Negritto, M. C., & Bailis, A. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1228 · Cited by 14
Origins and clinical relevance of proteoforms in pediatric malignancies
Lorentzian, A. C., Uzozie, A. C., & Lange, P. F. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1575206 · Cited by 14

Authors: Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C.-H., Nichols, K. E., & Downing, J. R.
Affiliations: St. Jude Children's Research Hospital (US)
Washington University in St. Louis (US)
ORCID: Zhang, Jinghui
Walsh, Michael F.
Wu, Gang
Edmonson, Michael N.
Gruber, Tanja A.
Easton, John
Ma, Xiaotu
Zhou, Xin
Yergeau, Donald A.
Wilkinson, Mark R.
Chen, Xiang
McGee, Rose B.
Nuccio, Regina
Quinn, Emily
Rusch, Michael
Patel, Aman
Becksfort, Jared B.
Weaver, Meaghann S.
Ding, Li
Mardis, Elaine R.
Wilson, Richard K.
Gajjar, Amar
Ellison, David W.
Pappo, Alberto S.
Pui, Ching-Hon
Nichols, Kim E.
Downing, James R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-12-10
Volume: 373
Issue: 24
Pages: 2336-2346
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1508054
PMC: PMC4734119
OpenAlex: W2303408208
Cited by: 1,345
References: 56
Citations by year: 2026: 90 · 2025: 113 · 2024: 151 · 2023: 132 · 2022: 134 · 2021: 161 · 2020: 141 · 2019: 122 · 2018: 113 · 2017: 101 · 2016: 76 · 2015: 5
FWCI: 67.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Cancer Institute (R01CA180006, CA21765, P30CA021765)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: germline mutations, cancer susceptibility genes, childhood cancer, children and adolescents, TP53, APC, BRCA2, neurofibromatosis type 1, PMS2, RB1, RUNX1, tumor suppressor, pathogenicity assessment, family history of cancer, genetic counseling, autism spectrum disorder
MeSH terms: Adolescent, Autistic Disorder, Child, Female, Genes, Dominant, Humans, Male, Neoplasms, Genome, Human, Sequence Analysis, DNA, Germ-Line Mutation, SEER Program, Genetic Predisposition to Disease, Genes, Neoplasm, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Germline Mutations in Predisposition Genes in Pediatric Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks